Purdue To Settle OxyContin Antitrust MDL: Atty
Purdue Pharma LP has settled a slew of suits brought by indirect buyers of OxyContin accusing it of stifling generic competition by filing bogus patent litigation, just days after its lawyer...To view the full article, register now.
Already a subscriber? Click here to view full article